KraneShares Emerging Markets Healthcare Index ETF
KMED
KMED was delisted on the 18th of October, 2023.
5 hedge funds and large institutions have $1.87M invested in KraneShares Emerging Markets Healthcare Index ETF in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
25% more funds holding
Funds holding: 4 → 5 (+1)
11% more capital invested
Capital invested by funds: $1.68M → $1.87M (+$185K)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$47.7K |
| 2 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$6.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$20.9K |
KMED Hedge Fund Activity: Q2 2021 in Review
5 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in KraneShares Emerging Markets Healthcare Index ETF (KMED) for Q2 2021, worth a combined $1.87M — up 11% from $1.68M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new KMED positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Jane Street, adding an estimated $47.7K. The largest seller was UBS Group, cutting an estimated $20.9K.
- 5 institutional investors held KraneShares Emerging Markets Healthcare Index ETF (KMED) as of Q2 2021, up from 4 in Q1 2021.
- Funds reported $1.87M of KraneShares Emerging Markets Healthcare Index ETF stock for Q2 2021, up 11% quarter-over-quarter.
- 1 fund opened new KraneShares Emerging Markets Healthcare Index ETF positions in Q2 2021 and 0 closed out, a net change of +1 holder.
- The largest KraneShares Emerging Markets Healthcare Index ETF buyer in Q2 2021 was Jane Street, an estimated $47.7K added.
- The largest KraneShares Emerging Markets Healthcare Index ETF seller in Q2 2021 was UBS Group, an estimated $20.9K sold.
Based on aggregated 13F filings for Q2 2021.